melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
About Us
Our Services
HIGH THROUGHPUT IN VIVO PHARMACOLOGY:
DISCOVERY SERVICES:
Our Technology
Partnering with Us
Press & Publications
Contact Us
melior melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling

Our Technology why multiplexing?


Multiplexing is not cassette dosing; rather, it is a proprietary method used to integrate multiple in vivo models. This approach reduces the number of personnel, test subjects and amount of compound required to conduct the screens. The result is an increase in efficiency and a reduction in the overall cost compared to approaches that run assays separately.
 
home